Mechanistically, BPzoledronic acid exhibits an anti-breast cancer effect, namely the inhibition of cell proliferation, adhesion, migration, and invasion via the suppression of the expression of SDC1 and 2, whereas SDC4 was upregulated [175]. The gene discussed is SDC4; the disease is breast cancer.